Structures by: Montis R.
Total: 120
C26H18F12N4O2,2(C16H36N),2(C2H3O2)
C26H18F12N4O2,2(C16H36N),2(C2H3O2)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 5 2138-2149
a=19.1107(15)Å b=8.4202(7)Å c=42.107(3)Å
α=90° β=96.582(5)° γ=90°
2(C25H17F12N5O2),2(C16H36N),HO4P,C2H6OS
2(C25H17F12N5O2),2(C16H36N),HO4P,C2H6OS
Dalton transactions (Cambridge, England : 2003) (2015) 44, 5 2138-2149
a=12.5362(16)Å b=32.550(4)Å c=23.279(3)Å
α=90° β=97.732(2)° γ=90°
3(C23H19F6N5O2),2(C16H36N),O4S,H2O
3(C23H19F6N5O2),2(C16H36N),O4S,H2O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 5 2138-2149
a=29.281(6)Å b=14.001(2)Å c=28.838(6)Å
α=90° β=113.087(3)° γ=90°
2(C26H18F12N4O2),2(C16H36N),2(C2H6OS),CO3
2(C26H18F12N4O2),2(C16H36N),2(C2H6OS),CO3
Dalton transactions (Cambridge, England : 2003) (2015) 44, 5 2138-2149
a=20.944(3)Å b=24.898(3)Å c=38.318(5)Å
α=90° β=90° γ=90°
C24H20F6N4O2,2(C16H36N),2(C2H3O2),3(H2O)
C24H20F6N4O2,2(C16H36N),2(C2H3O2),3(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 5 2138-2149
a=34.550(2)Å b=8.7957(5)Å c=43.222(3)Å
α=90° β=91.801(4)° γ=90°
Ac20_5
2(C16H36N),C26H21N5O2,H2O7P2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 7 3078-3085
a=22.394(12)Å b=16.369(8)Å c=17.539(10)Å
α=90° β=90° γ=90°
2(C26H21N5O2),4(C16H36N),4(H2O4P),0.5(H2O)
2(C26H21N5O2),4(C16H36N),4(H2O4P),0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 7 3078-3085
a=16.1474(7)Å b=28.4487(12)Å c=26.5040(9)Å
α=90° β=90° γ=90°
C31H20F12N6O3,C16H36N,Cl
C31H20F12N6O3,C16H36N,Cl
Dalton transactions (Cambridge, England : 2003) (2016) 45, 29 11892-11897
a=12.919(5)Å b=13.561(6)Å c=14.982(6)Å
α=107.158(9)° β=93.703(8)° γ=90.818(6)°
C29H22F6N6O3,2(Cl),2(C16H36N)
C29H22F6N6O3,2(Cl),2(C16H36N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 29 11892-11897
a=11.210(3)Å b=11.448(3)Å c=25.187(8)Å
α=96.774(4)° β=93.788(5)° γ=96.805(5)°
C31H20F12N6O3,C16H36N,C2H3O2
C31H20F12N6O3,C16H36N,C2H3O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 29 11892-11897
a=14.0834(10)Å b=14.4242(10)Å c=15.5069(11)Å
α=110.124(3)° β=90.770(3)° γ=114.879(3)°
C20H24N8O8
C20H24N8O8
Crystal Growth & Design (2012) 12, 3 1520-1530
a=13.1974(3)Å b=6.9662(2)Å c=26.2816(8)Å
α=90° β=97.847(1)° γ=90°
2-acetyloxy-3-acetylaminobenzoic acid
C11H11NO5
Crystal Growth & Design (2013) 13, 7 2906
a=18.379(4)Å b=4.3789(11)Å c=13.658(3)Å
α=90.00° β=90.00° γ=90.00°
2-acetyloxy-5-acetylaminobenzoic acid
C11H11NO5
Crystal Growth & Design (2013) 13, 7 2906
a=7.9457(2)Å b=8.0305(2)Å c=9.6719(2)Å
α=110.8010(10)° β=99.754(2)° γ=105.371(2)°
C9H7.43F0.57O4
C9H7.43F0.57O4
Crystal Growth & Design (2013) 13, 7 2906
a=9.8775(5)Å b=4.8547(2)Å c=18.3430(10)Å
α=90.00° β=104.957(2)° γ=90.00°
C20H24N8O8
C20H24N8O8
Crystal Growth & Design (2012) 12, 3 1520-1530
a=13.1974(3)Å b=6.9662(2)Å c=26.2816(8)Å
α=90° β=97.847(1)° γ=90°
C12H14N4O6
C12H14N4O6
Crystal Growth & Design (2012) 12, 3 1520-1530
a=7.9765(18)Å b=8.067(3)Å c=12.162(5)Å
α=77.59(3)° β=77.68(3)° γ=69.92(3)°
C5H8BrIN2OS
C5H8BrIN2OS
CrystEngComm (2017)
a=7.786(3)Å b=8.719(4)Å c=9.403(4)Å
α=62.62(4)° β=89.52(4)° γ=66.88(4)°
4-methoxyaspirin
C10H10O5
CrystEngComm (2011) 13, 10 3390
a=5.06880(10)Å b=9.4619(3)Å c=20.0281(6)Å
α=90.00° β=94.069(2)° γ=90.00°
2-acetyloxy-5-iodobenzoic acid
C9H7IO4
CrystEngComm (2010) 12, 3 953
a=10.7838(5)Å b=4.7168(2)Å c=19.5502(8)Å
α=90.00° β=96.630(2)° γ=90.00°
C26H18F12N4O2,C2H6OS
C26H18F12N4O2,C2H6OS
Dalton transactions (Cambridge, England : 2003) (2015) 44, 5 2138-2149
a=26.454(2)Å b=12.7445(9)Å c=8.9389(5)Å
α=90° β=94.842(3)° γ=90°